Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia.  Nine HHMI investigators and one HHMI Professor are elected to the American Academy of Arts and Sciences. HHMI investigator Brian Druker honored for role in developing new cancer drug. Brief summaries of the research carried out by the 12 patient-oriented researchers selected by HHMI in 2002